Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Facilitating cells: role in inducing transplantation tolerance

Chhabra, Anita Yogendra; Ildstad, Suzanne T.

Current Opinion in Organ Transplantation: October 2018 - Volume 23 - Issue 5 - p 546–551
doi: 10.1097/MOT.0000000000000563
REGULATORY IMMUNE CELLS IN ORGAN TRANSPLANTATION AND THEIR THERAPEUTIC APPLICATION: Edited by Angus W. Thomson

Purpose of review This review discusses the role and mechanisms by which facilitating cells promote stem cell engraftment and induce tolerance in HLA-disparate kidney transplant recipients.

Recent finding Facilitating cells in both mice and human are heterogeneous, consisting of several subpopulations. They have been shown to enhance stem cell engraftment in allogeneic recipients. They also increase hematopoietic stem cells (HSC) clonogenicity, enhance migration and homing of stem cells via secretion of cytokines/chemokines/growth factors, prevent apoptosis of stem cells and induce regulatory cells. This review summarizes the findings that led to the development of chimerism-based induction of tolerance using FCRx (a mobilized blood product enriched in stem cells and facilitating cells) in allogenic kidney transplant patients.

Summary A phase-2 clinical trial based on FCRx therapy has been successful in inducing tolerance to living donor kidney allografts, leading to withdrawal of immunosuppression in over 70% of patients transplanted. The ultimate goal of establishing tolerance in the absence of immunosuppresive drugs can be achieved using FCRx therapy.

Institute for Cellular Therapeutics, University of Louisville, Louisville, Kentucky, USA

Correspondence to Suzanne T. Ildstad, MD, Director, Institute for Cellular Therapeutics, The Jewish Hospital Distinguished Professor of Transplantation, Distinguished University Scholar, Professor of Surgery, Microbiology and Immunology, Physiology, University of Louisville, CEO, Regenerex, LLC, 570 S. Preston Street, Suite 404, Louisville, KY 40202-1760, USA. Tel: +1 502 852 2080; fax: +1 502 852 2085; e-mail: suzanne.ildstad@louisville.edu

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.